Don’t miss out - Get your tickets early!

Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

The endocannabinoid system (ECS) is essential for human homeostasis. An ancient signalling system ubiquitous in vertebrates. There is increasing evidence that ECS dysregulation results in numerous diseases as well inhibiting the bodies innate healing response. As we look to the future of psychedelic assisted therapy programmes endocannabinoid medicine will have a vital role to play in preparing people for the assisted psychotherapy process.

This session will explore:

What is the ECS?
How is the ECS involved in the development and treatment of PTSD / anxiety / depression?
How can we manipulate the ECS to improve assisted psychotherapy outcomes?

WEBINAR SESSION

Date: Wednesday 13 January 2021
Time: 7:25pm for 7:30pm start – 8:45pm (incl Q&A) (AEDT)

The presentation WILL BEGIN AT 7:30pm.

Location: Online. A link will be emailed to you with the viewing details.

Following the presentation there will be a Q & A panel with Dr Jamie Rickcord, Tania de Jong AM and Dr Alana Roy. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

More about the presenters

Dr Jamie Rickcord
MBBS, BSC (HONS), FRACGP
Founder Ananda Clinics

Dr Jamie has practiced medicine since graduating from Imperial College, London in 2006. For the last eight years he has worked as a GP in the Northern Rivers. His current focus is endocannabinoid medicine and developing new models to encourage healing, wellbeing and numinosity. Dr Jamie has recently joined the Mind Medicine practitioner team and is actively developing the major role cannabinoids and psychedelics have in the next paradigm of mental health treatments.

Tania de Jong AM (Moderator)
LL.B (Hons), GradDipMus
Founder & Deputy Chair of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 3 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

Dr Alana Roy
Ph. D Psychology, B. A Social Work (MHSW)
Practice Manager

Dr Alana Roy is the Practice Manager of Mind Medicine Australia, a Psychologist and a Social Worker. She is also a Research Fellow at the University of Melbourne and teaches and supervises students across multiple universities.

Alana has also worked in frontline sexual assault services for 13 years providing therapy to children, women and men working with victims, police and forensic doctors. She is passionate about emotion focused therapy, EMDR and trauma informed practices. Although these therapies are effective for a range of trauma survivors many victims continue to live with unbearable pain.

The reality is that there is an epidemic of sexual abuse in our world and we require radical treatments to tackle this global issue. Alana's own experiences of trauma and burnout lead her to seek out legal psychedelic assisted treatment overseas. It truly was 10 years of psychotherapy (insights) in one night. However, it wasn't 10 years of change in one night. Alana came back to Australia and was unable to locate a professional to help integrate these experiences. She realised that Australia needed a skilled mental health sector to help support victims who use psychedelics to overcome their trauma to process and integrate these transformative and healing experiences. Australia is falling behind in the global psychedelic renaissance.

Since this treatment, Alana has dedicated her life to researching and developing clinical services in the field of psychedelic and plant medicines. Mind Medicine Australia is a ground-breaking NGO advocating for the responsible use of psychedelic-assisted therapies.

Alana hopes to help make history in supporting legislative and policy change so that victims and all people with mental health issues have access to these medicines.

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.

Contact the host of Mind Medicine Australia FREE Webinar Series - Endocannabinoid medicine; A gateway to psychedelic assisted psychotherapy

There were 0 errors found in the information you submitted: